Coya Therapeutics Inc
Coya Therapeutics Inc (COYA) Option Chain
Read more
Tracking the COYA option chain helps you see every strike and expiry on Coya Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of COYA options activity at a glance. Use our scanner to monitor the COYA option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For COYA stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where COYA options are being actively traded, and where they are not.
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 42.39 | 10 | 0 | 4.38 | 0.52 | — | 4.90 | 2.50 | -16.67 | — | 0.05 | 0.00 | 0.05 | 0 | 10 | 57.62 |
| 91.55 | 250 | 0 | 4.90 | 0.00 | — | 4.90 | 5.00 | +66.67 | — | 2.45 | 1.98 | 0.47 | 0 | 0 | 8.45 |
| 98.90 | 4 | 0 | 0.75 | 0.00 | — | 0.75 | 7.50 | +150.00 | 2.20 | 6.90 | 4.48 | 0.07 | 0 | 0 | 1.09 |
| 99.84 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 10.00 | +233.33 | 4.80 | 9.20 | 6.98 | 0.02 | 0 | 0 | 0.16 |
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank82.94% High
- Market cap (M$)71
- 52 weeks high-54.38%
- 52 weeks low11.03%
- Analyst recommendationStrong Buy
1.00 - Target price$15.21
403.64% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-10
- P/E—
- Future P/E—
- EPS (ttm)-1.33
- EPS growth next 5 years2.56%
As of Nov 16, 2026